3.39
-0.36 (-9.6%)
-0.36 (-9.6%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 155,826 |
|
|||||
| News | (8) | ||||||
| Day High | 3.78 | Low High |
|||||
| Day Low | 3.40 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Yumanity Therapeutics Inc | YMTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.36 | -9.6% | 3.39 | 20:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.78 | 3.40 | 3.78 | 3.48 | 3.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 870 | 155,826 | $ 3.53 | $ 549,318 | - | 3.40 - 23.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:08:48 | formt | 100 | $ 3.39 | USD |
Period:
Draw Mode:
Yumanity Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 34.95M | 10.31M | 7.15M | $ 6.90M | $ - | -21.57 | -0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 65.00k | 8.00% |
Yumanity Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.26 | 4.43 | 3.40 | 4.07 | 220,658 | -0.87 | -20.42% |
| 1 Month | 9.34 | 9.34 | 3.40 | 5.23 | 348,443 | -5.95 | -63.7% |
| 3 Months | 11.15 | 13.90 | 3.40 | 7.89 | 229,218 | -7.76 | -69.6% |
| 6 Months | 15.26 | 16.89 | 3.40 | 9.20 | 167,531 | -11.87 | -77.79% |
| 1 Year | 20.07 | 23.47 | 3.40 | 11.60 | 120,602 | -16.68 | -83.11% |
| 3 Years | 20.07 | 23.47 | 3.40 | 11.60 | 120,602 | -16.68 | -83.11% |
| 5 Years | 20.07 | 23.47 | 3.40 | 11.60 | 120,602 | -16.68 | -83.11% |
Yumanity Therapeutics Description
| Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease. |
